Blue Owl Capital Corp II
Other · MD · SEC filings ↗ · Compare ⊕
Financials
SEC XBRL · annual| FY25 | FY24 | FY23 | FY22 | |
|---|---|---|---|---|
| Revenue | — | — | — | — |
| Operating income | — | — | — | — |
| Net income | $24.1M | $82.0M | $129.8M | $73.2M |
| Total assets | $1.65B | $2.00B | $2.19B | $2.33B |
| Total liabilities | $698.4M | $880.3M | $927.1M | $1.03B |
| Equity | $950.4M | $1.12B | $1.26B | $1.30B |
| EPS (diluted) | $0.20 | $0.61 | $0.90 | $0.49 |
| Shares out. | 128.7M | 141.4M | 147.4M | 146.5M |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2025- Operating margin
- —
- Net margin
- —
- Return on equity
- 2.5%
- Return on assets
- 1.5%
- Return on capital (ROCE)
- —
- Liabilities / assets
- 42.4%
- Debt / equity
- 0.73×
- Book value / share
- $7.39
- Revenue growth (YoY)
- —
- Net income growth (YoY)
- −70.6%
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Financial health
forensic scores · FY2025- Accruals / assets
- −22.3%clean
- Piotroski F-Score
- 5/6mixed
Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast.
Signs
● 3 good- Conservative leverage (liabilities < 50% of assets)
- Positive operating cash flow
- Clean earnings (low accruals)
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
Material events
SEC Form 8-K · most recent- Other material eventApr 16, 2026
- Other material eventMar 6, 2026
- Results of operationsFeb 26, 2026
- Entered a material agreement · Completed an acquisition or disposition · Regulation FD disclosure · Other material eventFeb 18, 2026
- Results of operationsJan 30, 2026
- Results of operationsDec 31, 2025
- Results of operationsNov 26, 2025
- Terminated a material agreement · Regulation FD disclosureNov 19, 2025
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.
Recent SEC filings
All filings ↗- 40-17GMay 27, 2026
- N-23C-2May 11, 2026
- 10-QMay 8, 2026
- SC TO-T/ATENDER OFFER STATEMENTApr 27, 2026
- 8-KApr 16, 2026
- DEFA14AApr 10, 2026
- DEFA14AApr 1, 2026
- DEF 14AApr 1, 2026
- SC TO-T/ATENDER OFFER STATEMENTMar 24, 2026
- SC TO-T/ATENDER OFFER STATEMENTMar 20, 2026
- SC TO-T/ATENDER OFFER STATEMENTMar 16, 2026
- SC 14D9Mar 13, 2026
- SC TO-T/ATENDER OFFER STATEMENTMar 11, 2026
- SC TO-TTENDER OFFER STATEMENTMar 6, 2026
- 8-KMar 6, 2026